Search Within

Brian Kushner

  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Journal Article (15)
  2. Meeting Abstract (12)
  3. Book Section (1)
Groups
  1. Neuroblastoma Service (28)
  2. Pediatrics, Department of (28)
  3. Sloan Kettering Institute Postdocs (28)
  4. Center for Molecular Imaging and Biotechnology (CMIB) (24)
  5. GSK Faculty (24)
  6. Tow Center for Developmental Oncology (TCDO) (24)

More Groups

People
  1. Shakeel Modak (28)
  2. Nai-Kong Cheung (22)
  3. Ellen Basu (19)
  4. Stephen Roberts (18)
  5. Audrey Mauguen (15)
  6. Irene Cheung (11)

More People

Years
  1. 2025 (1)
  2. 2024 (3)
  3. 2023 (5)
  4. 2022 (3)
  5. 2021 (5)
  6. 2020 (2)

More Years

Publications
  1. Pediatric Blood and Cancer (9)
  2. Journal of Clinical Oncology (3)
  3. Cancer Research (2)
  4. Clinical Cancer Research (2)
  5. Cancers (1)
  6. Frontiers in Oncology (1)

More Publications

Publishers
  1. Wiley Periodicals, Inc (9)
  2. American Association for Cancer Research (4)
  3. American Society of Clinical Oncology (3)
  4. MDPI (2)
  5. Springer (2)
  6. American Medical Association (1)

More Publishers

Results (28)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Naxitamab-based chemoimmunotherapy for resistant high-risk neuroblastoma: Results of "HITS" phase II study
    Meeting Abstract

    Modak, S.; Kushner, B. H.; Mauguen, A.; Castañeda, A.; Varo, A.; Gorostegui, M.; Muñoz, J. P.; Santa-Maria, V.; Basu, E. M.; Cardenas, F. I.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Bone marrow surveillance of pediatric cancer survivors identifies clones that predict therapy-related leukemia
    Journal Article

    Spitzer, B.; Rutherford, K. D.; Gundem, G.; McGovern, E. M.; Millard, N. E.; Arango Ossa, J. E.; Cheung, I. Y.; Gao, T.; Levine, M. F.; Zhang, Y.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Phase I trial of oral yeast-derived β-glucan to enhance anti-GD2 immunotherapy of resistant high-risk neuroblastoma
    Journal Article

    Iglesias Cardenas, F.; Mauguen, A.; Cheung, I. Y.; Kramer, K.; Kushner, B. H.; Ragupathi, G.; Cheung, N. K. V.; Modak, S.
    Cancers (2021)

    Fulltext@MSK | Save
  • Association of BRAF V600E mutations with vasoactive intestinal peptide syndrome in MYCN-amplified neuroblastoma
    Meeting Abstract

    Shahid, S.; Kushner, B.; Modak, S.; Basu, E.; Rubin, E.; Gundem, G.; Papaemmanuil, E.; Roberts, S.
    Pediatric Blood and Cancer (2021)

    Fulltext@MSK | Save
  • Association of BRAF V600E mutations with vasoactive intestinal peptide syndrome in MYCN-amplified neuroblastoma
    Journal Article

    Shahid, S.; Kushner, B. H.; Modak, S.; Basu, E. M.; Rubin, E. M.; Gundem, G.; Papaemmanuil, E.; Roberts, S. S.
    Pediatric Blood and Cancer (2021)

    Fulltext@MSK | Save
  • Mandibular metastases in neuroblastoma: Outcomes and dental sequelae
    Journal Article

    Singh, A.; Modak, S.; Solano, A. K.; Kushner, B. H.; Wolden, S.; Huryn, J.; Estilo, C. L.
    Pediatric Blood and Cancer (2021)

    Fulltext@MSK | Save
  • Survival impact of anti-GD2 antibody response in a phase II ganglioside vaccine trial among patients with high-risk neuroblastoma with prior disease progression
    Journal Article

    Cheung, I. Y.; Cheung, N. K. V.; Modak, S.; Mauguen, A.; Feng, Y.; Basu, E.; Roberts, S. S.; Ragupathi, G.; Kushner, B. H.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Survival impact of anti-GD2 antibody response - A phase II ganglioside vaccine trial in relapsed neuroblastoma
    Meeting Abstract

    Cheung, I. Y.; Cheung, N. K. V.; Modak, S.; Mauguen, A.; Basu, E.; Roberts, S. S.; Ragupathi, G.; Kushner, B. H.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • High-dose naxitamab (humanized-3F8) plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor (GM-CSF) for Resistant Osteomedullary Neuroblastoma: Major Responses and Outpatient Treatment in a Phase II Trial
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Pandit-Taskar, N.; Cheung, N. K.
    Pediatric Blood and Cancer (2020)

    Fulltext@MSK | Save
  • High-dose naxitamab (humanized-3F8) PLUS stepped-up dosing of granulocyte-macrophage colony-stimulating factor for neuroblastoma: Outpatient treament low immunogenicity, and major responses in a phase II trial
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Pandit-Taskar, N.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save